A detailed history of Capital Planning Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 42,598 shares of MRK stock, worth $4.84 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
42,598
Previous 41,710 2.13%
Holding current value
$4.84 Million
Previous $5.5 Million 4.18%
% of portfolio
0.93%
Previous 0.99%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $109,934 - $118,068
888 Added 2.13%
42,598 $5.27 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $131,131 - $152,798
1,158 Added 2.86%
41,710 $5.5 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $59,006 - $64,212
589 Added 1.47%
40,552 $4.42 Million
Q3 2023

Oct 30, 2023

SELL
$102.95 - $114.33 $4,323 - $4,801
-42 Reduced 0.1%
39,963 $4.11 Million
Q2 2023

Aug 01, 2023

SELL
$108.61 - $118.38 $72,768 - $79,314
-670 Reduced 1.65%
40,005 $4.62 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $57,028 - $63,632
-554 Reduced 1.34%
40,675 $4.33 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $14,864 - $19,058
170 Added 0.41%
41,229 $4.57 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.92 Million - $2.16 Million
22,767 Added 124.46%
41,059 $3.54 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $1,168 - $1,324
14 Added 0.08%
18,292 $1.67 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $1,470 - $1,648
20 Added 0.11%
18,278 $1.5 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $111,311 - $139,431
-1,540 Reduced 7.78%
18,258 $1.4 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $1.1 Million - $1.21 Million
-15,340 Reduced 43.66%
19,798 $1.49 Million
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $239,054 - $264,418
-3,400 Reduced 8.82%
35,138 $2.73 Million
Q1 2021

Apr 30, 2021

BUY
$68.86 - $81.11 $193,496 - $227,919
2,810 Added 7.86%
38,538 $2.97 Million
Q4 2020

Feb 04, 2021

SELL
$71.77 - $79.65 $34,449 - $38,232
-480 Reduced 1.33%
35,728 $2.92 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $10,757 - $12,193
147 Added 0.41%
36,208 $3 Million
Q2 2020

Aug 06, 2020

BUY
$70.42 - $80.13 $225,696 - $256,816
3,205 Added 9.75%
36,061 $2.79 Million
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $33,897 - $46,983
-535 Reduced 1.6%
32,856 $2.53 Million
Q4 2019

Feb 03, 2020

BUY
$77.58 - $87.54 $135,687 - $153,107
1,749 Added 5.53%
33,391 $3.04 Million
Q3 2019

Nov 05, 2019

SELL
$76.08 - $82.93 $27,084 - $29,523
-356 Reduced 1.11%
31,642 $2.66 Million
Q2 2019

Aug 09, 2019

BUY
$69.84 - $81.59 $55,522 - $64,864
795 Added 2.55%
31,998 $2.68 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $62,274 - $71,027
-895 Reduced 2.79%
31,203 $2.6 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $57,345 - $66,549
879 Added 2.82%
32,098 $2.45 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $1.17 Million - $1.38 Million
20,317 Added 186.36%
31,219 $2.22 Million
Q2 2018

Aug 08, 2018

BUY
$50.83 - $59.72 $554,148 - $651,067
10,902 New
10,902 $662,000
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $194,667 - $226,258
-3,820 Closed
0 $0
Q4 2017

Feb 08, 2018

BUY
$51.62 - $61.64 $197,188 - $235,464
3,820
3,820 $215,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.